rs200483866
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001211.6(BUB1B):c.180-3C>T variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00049 in 1,612,716 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001211.6 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BUB1B | NM_001211.6 | c.180-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000287598.11 | NP_001202.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BUB1B | ENST00000287598.11 | c.180-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_001211.6 | ENSP00000287598 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000598 AC: 91AN: 152128Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000911 AC: 229AN: 251446Hom.: 3 AF XY: 0.000839 AC XY: 114AN XY: 135900
GnomAD4 exome AF: 0.000479 AC: 700AN: 1460588Hom.: 6 Cov.: 31 AF XY: 0.000502 AC XY: 365AN XY: 726696
GnomAD4 genome AF: 0.000598 AC: 91AN: 152128Hom.: 0 Cov.: 31 AF XY: 0.000538 AC XY: 40AN XY: 74310
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 18, 2021 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Mosaic variegated aneuploidy syndrome 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 12, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at